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Gibberellins (GAs) are a class of plant hormones involved in the
regulation of flower development in Arabidopsis. The GA-deficient
ga1-3 mutant shows retarded growth of all floral organs, especially
abortive stamen development that results in complete male ste-
rility. Until now, it has not been clear how GA regulates the
late-stage development of floral organs after the establishment of
their identities within floral meristems. Various combinations of
null mutations of DELLA proteins can gradually rescue floral
defects in ga1-3. In particular, the synergistic effect of rga-t2 and
rgl2-1 can substantially restore flower development in ga1-3. We
find that the transcript levels of floral homeotic genes APETALA3
(AP3), PISTILLATA (PI), and AGAMOUS (AG) are immediately up-
regulated in young flowers of ga1-3 upon GA treatment. Using a
steroid-inducible activation of RGA, we further demonstrated that
these floral homeotic genes are transcriptionally repressed by RGA
activity in young flowers whereas the expression of LEAFY (LFY)
and APETALA1 (AP1) is not substantially affected. In addition, we
observed the partial rescue of floral defects in ga1-3 by overex-
pression of AG. Our results indicate that GA promotes the expres-
sion of floral homeotic genes by antagonizing the effects of DELLA
proteins, thereby allowing continued flower development.
F lower development starts with the specification of floralmeristem identity, and of floral organ identity within nascent
floral meristems flanking an inflorescence meristem. During this
process, LEAFY (LFY) stands out as a major regulator in both
integrating upstream floral inductive signals and controlling
three classes of downstream floral homeotic genes, called A, B,
and C function genes, respectively. These classes of downstream
genes control f loral organ identity in discrete domains (1–3).
Although it has been clear that combinatorial activation of A, B,
and C function genes governs the identity of different floral
organs (3–5), little is known about how a young floral bud with
established floral organ identities continues to develop into a
mature flower. It is possible that floral homeotic genes play
consistent roles in initiation and further promotion of floral
organ growth because the region-specific expression of these
genes is present throughout the whole process of flower devel-
opment (6–11). Indeed, the C function gene AGAMOUS (AG)
has been suggested to function not only in the early specification
of stamen and carpel identity, but also in the late patterning of
carpel structures (12). It is noteworthy that, as a major promoter
of floral homeotic genes, LFY is not expressed in flowers after
stage 5 (13). If f loral homeotic genes are the regulators required
for both floral organ identity and their continued development,
the promotion of floral homeotic genes at later stages of flower
development should be regulated by mechanisms other than
LFY-dependent ones. The gibberellin (GA)-deficient ga1-3 mu-
tant develops flowers with retarded growth of all f loral organs
despite their normal identities (14, 15), which provides a useful
experimental system to distinguish between the different mech-
anisms involved in the establishment of floral organ identity and
at least some aspects of the later development of floral organs.
Gibberellins are one class of tetracyclic diterpenoid phyto-
hormones affecting many aspects of plant growth and develop-
ment, including seed germination, root growth, stem elongation,
leaf expansion, f loral induction, and flower development (16,
17). Recent advances have shown that GA regulates various
plant developmental programs by suppressing a group of
DELLA protein nuclear repressors (18–24). There are a total of
five DELLA proteins (GAI, RGA, RGL1, RGL2, and RGL3)
encoded in the Arabidopsis genome. All of these proteins contain
a conserved N-terminal DELLA domain, which is possibly
involved in the inactivation of these proteins by GA signals (18,
25). GAI and RGA are negative regulators of GA responses in
the control of stem elongation, f lowering time, and root growth.
Removing both gene functions causes a synergistic suppression
of the corresponding defects in ga1-3 mutants (20, 21, 24).
Similarly, RGL2 is a major repressor of seed germination
because rgl2 null mutations can significantly promote the ger-
mination of ga1-3 seeds, which require GA for normal germi-
nation (22). Although it has been suggested that GA overcomes
the function of DELLA repressors by inducing degradation of
these proteins by means of a ubiquitinproteasome-dependent
pathway (25–28), the mechanisms by which these proteins con-
trol downstream developmental processes have not yet been
clarified.
In this study, we find that GA regulates flower development
by opposing the function of several DELLA repressors and
thereby partly promoting the expression of the floral homeotic
genes APETALA3 (AP3), PISTILLATA (PI), and AG. Absence
of RGA and RGL2 function is almost sufficient to restore
normal flower development in ga1-3 (29), indicating that both
genes are major repressors of GA responses in this specific
process. By using a steroid-inducible system for the activation of
RGA, we present evidence showing that AP3, PI, and AG are
targets of transcriptional repression by RGA. Moreover, over-
expression of AG causes partial rescue of abortive stamen
development in ga1-3. Our results thus suggest that continuous
maintenance of floral homeotic gene expression is important for
normal flower development and that DELLA proteins, espe-
cially RGA, play critical roles in linking the GA-signaling
pathway with homeotic gene activity in flower development.
Materials and Methods
Plant Materials. All Arabidopsis mutants used in this study are in
the Landsberg erecta (Ler) background unless stated otherwise.
They were grown at 22°C in continuous light. To break dor-
mancy, all seeds with ga1-3 background were imbibed in 100 M
GA at 4°C for 7 days, and then rinsed thoroughly with water
before sowing. Mutant lines ga1-3, rgl1-1, rgl2-1, gai-t6, rga-t2,
ga1-3 rgl1-1, ga1-3 rgl2-1, ga1-3 gai-t6, ga1-3 rga-t2, and ga1-3
gai-t6 rga-t2 have been described (22). The other mutant lines in
this study were created by cross-pollination between the above
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relevant mutants, and their genotypes were verified as reported
(21, 22).
To create ga1-3 rga-t2 35S::RGA-GR, ga1-3 rga-t2 was treated
weekly with 100 M GA and transformed with the binary vector
harboring the 35S::RGA-GR cassette. Transgenic plants con-
taining 35S::RGA-GR were screened by Basta selection and
further tested for phenotypic effects by dexamethasone treat-
ment. We isolated one transgenic line, which contains only one
transgene insertion and shows the phenotype closely resembling
ga1-3 after dexamethasone treatment, to cross with ga1-3 rgl2-1
rga-t2 to create ga1-3 rgl2-1 rga-t2 35S::RGA-GR.
To create 35S::AG-GR, Arabidopsis ecotype Landsberg erecta
(Ler) was transformed with the binary vector harboring the
35S::AG-GR cassette (T.I. and E.M.M., unpublished results). We
selected a transgenic line, which contains only one transgene
insertion and shows the phenotype closely resembling 35S::AG
after dexamethasone treatment, to cross with ga1-3 to generate
ga1-3 35S::AG-GR.
Dexamethasone treatment and sample collection were as
described (30).
Plasmid Constructs. We constructed a derivative pGreen0229TI
vector by cloning the caulif lower mosaic virus 35S coat protein
gene (35S) promoter with tandem enhancers and transcriptional
terminator into the KpnI and XhoI sites of pGreen0229 (31). The
hormone-binding domain of the rat glucocorticoid receptor
(GR) was amplified from pRI-GR (32) by the primers GR1
(5-TCCCCCGGGGGATCCTGAAGCTCGAA-3) and GR2
(5-GCTCTAGAGCTCAGTCATTTTTGATGA-3). The am-
plified GR fragment was cut with BamHI and XbaI and cloned
into the corresponding sites of the pGreen0229TI to generate
pGreen0229TI:GR. The entire RGA cDNA was amplified by
RT-PCR with the primers RGA-G1 (5-AACTGCAGAATC-
GAAACTCATAGCTGAA-3) and RGA-G2 (5-AAGGATC-
CCCGTGCGCCGCCGTCGAGAGTTTC-3). The resulting
fragment was digested by PstI and BamHI and subsequently
cloned into the corresponding sites of pGreen0229TI:GR to
create a 35S::RGA-GR cassette.
Analysis of Gene Expression. To investigate gene expression in
young flowers, we selected inflorescence apices containing floral
buds younger than stage 10. Total RNA was extracted by RNeasy
Plant Mini Kit (Qiagen, Valencia, CA) and reverse-transcribed
by using the ThermoScript RT-PCR system (Invitrogen). Under
our RT-PCR conditions, we performed 22–25 cycles of ampli-
fication to make sure that quantification for all genes examined
was within a linear range. The amplified PCR products were
detected as described (33). RT-PCR was repeated three times by
using samples collected separately.
Primers designed for RT-PCR were as follows: AP1-P1 (5-
GCACCTGAGTCCGACGTC-3) and AP1-P2 (5-GCGGC-
GAAGCAGCCAAGG-3) for APETALA1 (AP1); AP2-P1 (5-
TAGCCACCGGATCGTCCGCGGGTAAA-3) and AP2-P2
(5-GTTGTTGTTGGTTCATCCTGAGCCGCAT-3) for
APETALA2 (AP2); AP3-P1 (5-AGCTGCGTCGTCTTGAG-
GAT-3) and AP3-P2 (5-GGTTTTAGCAACACCATGCCT-
3) for AP3; PI-P1 (5-CTTACAACTGGAGCTCAGGCA-3)
and PI-P2 (5-GCTCGAGATTAAGACACACAG-3) for PI;
AG-P1 (5-GCTCAGGAACTTGGAAGGCAG-3) and
AG-P2 (5-TCACTCCAGGCCATTTCCTTC-3) for AG;
LFY-P1 (5-TGAAGGACGAGGAGCTT-3) and LFY-P2 (5-
TTGCCACGTGCCACTTC-3) for LFY; and TUB2-P1 (5-
ATCCGTGAAGAGTACCCAGAT-3) and TUB2-P2 (5-
TCACCTTCTTCATCCGCAGTT-3) for -tubulin (TUB2).
Some other primers were according to the following references:
WUSCHEL (WUS) (34), SUPERMAN (SUP) (35), and SEPA-
LLATA 3 (SEP3) (36).
In Situ Hybridization. Nonradioactive in situ hybridization was
performed according to a published protocol (37). Synthesis of
antisense probes has been described (38). Sections of both WT
and ga1-3 plants were placed on the same slide, which was
hybridized and detected under the same conditions. The com-
parable panels for different probes in in situ figures were
recorded from the same slide.
Results and Discussion
DELLA proteins in Arabidopsis include GAI, RGA, RGL1,
RGL2, and RGL3, which contain a conserved DELLA domain
at their N termini (18, 25). The stability of these proteins is
thought to be reduced in the presence of GA (25–28). It has been
suggested that DELLA proteins play repressive roles in various
aspects of plant growth and development (18–24). Flowers in
GA-deficient mutants ga1-3 possess undeveloped floral organs
Table 1. Classification of mutants in terms of their flower phenotype
Degree of
rescue of gal-3 Genotype* Flower phenotype
0 gal-3† Retarded growth of petals, stamens and pistils; male sterility with lack of mature pollen
1 gal-3 rgl1–1† Partial rescue of gal-3 with elongated pistils
gal-3 rgl2–1
gal-3 gai-t6
2 gal-3 rga-t2† Partial rescue of gal-3 with elongated petals, filaments, and pistils
gal-3 rgl1–1 rgl2–1
gal-3 rgl1–1 gai-t6
gal-3 rgl2–1 gai-t6
gal-3 rgl1–1 rgl2–1 gai-t6
3 ga1–3 rgl1–1 rga-t2† Partial rescue of gal-3 with more elongated petals, filaments, and pistils
gal-3 gai-t6 rga-t2
ga1–3 rgl1–1 gai-t6 rga-t2
4‡ gal-3 rgl2–1 rga-t2† Significant rescue of gal-3 with normal petals, pistils, and much developed stamens;
gal-3 rgl2–1 gai-t6 rga-t2 partial infertility of early arising flowers
5 gal-3 rgl1–1 rgl2–1 rga-t2† Almost total rescue of gal-3 with normal petals, stamens and pistils; normal fertility
gal-3 rgl1–1 rgl2–1 gai-t6 rga-t2
*All of the plants are of the same Landsberg erecta background.
†Representative mutants displaying different degrees of rescue of gal-3 are shown in Fig. 6.
‡Mutants in this degree generate two kinds of flowers: flowers arising at apical positions in a main inflorescence are fertile with significant rescue of gal-3 whereas
flowers arising at basal positions are still sterile with the degree 3 phenotype.
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in all four whorls. In particular, stamen development, including
filament elongation and pollen maturation, is abortive. Recently
reported work (29) and our observations (Fig. 6, which is
published as supporting information on the PNAS web site) show
that various combinations of null mutations of DELLA proteins
gai-t6, rga-t2, rgl1-1, and rgl2-1 (22) can rescue floral phenotypes
of ga1-3 to different degrees (Table 1). These results suggest that
RGA and RGL2 play major functions in repressing the contin-
ued growth of floral organs, and that the sequence of the
importance of DELLA proteins involved in flower development
is RGA, RGL2, RGL1, and GAI.
GA Promotes Flower Development Partly by Up-Regulating Floral
Homeotic Genes. To identify the downstream genes regulated by
GA signaling, we examined the expression of a set of genes
involved in floral patterning (12) upon GA treatment, which
included the floral meristem identity gene LFY, f loral homeotic
genes AP1, AP2, AP3, PI, and AG, and floral organ identity and
growth regulators WUS, SUP, and SEP3. Our results showed that
the expression of B and C function genes AP3, PI, and AG was
up-regulated in inflorescence apices of ga1-3, 2 h after GA
treatment (Fig. 1A) whereas expression of the other genes was
not substantially changed under the conditions tested (data not
shown). Although the selected inflorescence apices for RT-PCR
contained floral buds from stages 1 to 10, RNA of old floral buds
after stage 5 would be expected to constitute the greatest part of
the RNA isolated from the batch of floral buds (T.I. and E.M.M.,
unpublished data). Thus, up-regulation of these floral homeotic
genes after GA treatment mostly reflected a change in their
transcript levels in older floral buds after stage 5, after the time
when the floral meristems had already established floral organ
identity (39). Because GA treatment is sufficient to restore the
normal growth of floral organs in ga1-3 f lowers, we suggest that
the promotion of floral homeotic gene expression by GA sig-
naling may be important for the continued development of floral
buds to late-stage flowers, which have already established floral
organ identity.
To further investigate the potential involvement of GA signals
in the promotion of floral homeotic gene expression, we per-
formed in situ hybridization with relevant probes, to ga1-3 and
WT inflorescences. The B function gene AP3 and C function
gene AG were expressed at lower levels in ga1-3 than in WT
plants (Figs. 2 and 3) although their expression domains were not
changed. Such reduction of expression levels was observed
through the whole process of flower development in ga1-3 but
was particularly evident by stage 8 (Figs. 2 B and E and 3 B and
F). On the contrary, the expression of LFY, AP2 (data not
shown), and AP1 (Fig. 7, which is published as supporting
information on the PNAS web site) was not noticeably changed
in ga1-3, which is consistent with the RT-PCR result (Fig. 1 A).
As compared with their expression in ga1-3, expression of AP3
and AG was also higher in ga1-3 rgl2-1 rga-t2 (data not shown),
which showed significant rescue of floral defects of ga1-3,
indicating that GA may up-regulate the expression of target
genes in flower development by overcoming the effects of
DELLA proteins, especially RGA and RGL2.
Our data showed that GA can specifically and continuously
promote the expression of B and C function genes during flower
development, but not the LFY, AP1, and AP2 genes. The
significance of this finding lies in two aspects. First, compared
with the promotion of LFY expression by GA in the control of
f lowering time (40), LFY expression in emerging floral meris-
tems is independent of GA signaling. Flower phenotypes in ga1-3
suggest that, without GA, the normal expression of LFY in young
floral meristems is sufficient to promote the transcript levels of
f loral homeotic genes to establish normal floral organ identity,
but not enough to secure the continued development of floral
organs. Although we cannot exclude the possibility that GA
signaling may coordinate with LFY in early development of
floral meristems, our results suggest that GA can promote
expression of floral homeotic genes independently of LFY
activity in late-stage flowers, where LFY expression is absent.
Second, it has been reported that GA signals can greatly promote
petal development in ap1-1 and ap2-1 (41), indicating the
possible presence of an A function-independent pathway in
floral organogenesis that can be induced by GA signal trans-
duction. This finding may be explained by the observation that
GA can up-regulate B and C function genes, but not A function
genes.
Inducible Activation of RGA. Among the identified DELLA pro-
teins, RGA plays a more prominent role than GAI, RGL1, and
RGL2 in mediating GA signaling during flower development
(29). RGA contains a putative nuclear localization signal, and an
RGA fusion with green fluorescent protein is localized in the
nucleus of onion epidermal cells, indicating that RGA functions
Fig. 1. Expression of floral homeotic genes. (A) Expression of AP1, AP3, PI,
and AG in inflorescence apices of ga1-3 mutants mock-treated with 0.1%
ethanol (M), or treated with 100 M GA (GA). Expression analyses were done
after 2 h of treatment. (B) Time-course expression of AP1, AP3, PI, and AG in
inflorescence apices of ga1-3 rgl2-1 rga-t2 35S::RGA-GR plants mock-treated
with 0.03% ethanol and 0.015% Silwet L-77 (M) or treated with 10 M
dexamethasone and 0.015% Silwet L-77 (D). The -tubulin gene (TUB2) was
amplified as a quantitative control. The numbers below each lane indicate the
relative expression of each gene studied, calculated by first normalizing each
expression signal against the signal for TUB2 and then against the value of a
corresponding mock-treated sample, which is always set as 1.0.
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in the nucleus, perhaps as a transcriptional regulator (42). To
further elucidate the mechanistic links between GA signaling
and the activity of downstream genes in flower development, we
created a steroid-inducible version of RGA in transgenic plants
containing the RGA protein fused to the hormone-binding
domain of a rat GR under the control of a 35S promoter.
Posttranslational activation of RGA can be achieved in plants
transgenic for this construct by dexamethasone treatment, which
releases the fusion protein bound in the cytoplasm by means of
the rat protein domain to the nucleus (43).
The loss-of-function rga mutation can partially rescue a wide
range of phenotypic defects in ga1-3 plants, such as stem
elongation, f lowering time, and flower development (ref. 42 and
Fig. 6C). To closely examine the effects of RGA activity, we
transformed ga1-3 rga-t2 double mutants with 35S::RGA-GR.
The rationale is that, if the RGA-GR protein is biologically
functional, activation of RGA by dexamethasone should revert
the rescued phenotypes of ga1-3 rga-t2 to those of ga1-3. We
subsequently isolated one ga1-3 rga-t2 35S::RGA-GR transgenic
line, which showed phenotypic reversion from ga1-3 rga-t2 to
ga1-3 after weekly treatment with dexamethasone (Fig. 4 A and
B). This result indicates that the RGA-GR fusion protein has
similar biological functions as WT RGA and allows control of
RGA activity in a glucocorticoid-dependent manner.
Published work (29) and our genetic analysis indicate that
RGA is a key regulator of GA signaling involved in the control
of continued development of floral organs, as reflected in the
major phenotypic difference between ga1-3 rgl2-1 rga-t2 and
ga1-3 rgl2-1. The former genotype showed significant rescue of
floral defects as compared with the latter (Table 1). As RGL2
is the second most important DELLA protein after RGA in the
control of f lower development; lack of RGL2 activity in ga1-3
would potentially remove a majority of the redundant repressive
effects with RGA. Thus, in the ga1-3 rgl2-1 rga-t2 background,
the steroid-inducible activation of RGA could reveal major
genes responding to RGA activity. We crossed ga1-3 rga-t2
Fig. 2. In situ localization of AP3 expression in WT plants (A–C) and ga1-3 mutants (D–F). (A and D) An inflorescence apex with stage-2 and stage-4 flowers.
(B and E) A stage-8 flower. (C and F) A stage-10 flower. (Bars  100 m.)
Fig. 3. In situ localization of AG expression in WT plants (A–D) and ga1-3 mutants (E–H). (A and E) An inflorescence apex with a stage-4 flower. (B and F) A
stage-6 flower. (C and G) A stage-9 flower. (D and H) A stage-12 flower. (Bars  100 m.)
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35S::RGA-GR with ga1-3 rgl2-1 rga-t2 to generate ga1-3 rgl2-1
rga-t2 35S::RGA-GR. As expected, mock-treated ga1-3 rgl2-1
rga-t2 35S::RGA-GR (Fig. 4 C and D) showed the flower
phenotypes of ga1-3 rgl2-1 rga-t2 plants (Fig. 6E) whereas
dexamethasone-treated plants (Fig. 4 E and F) displayed the
phenotypes of ga1-3 rgl2-1 (Table 1).
Floral Homeotic Genes Function Downstream of GA Signaling. Using
the established steroid-inducible activation of RGA, we further
studied whether the expression of floral homeotic genes is
repressed by RGA activity. Dexamethasone treatment of inflo-
rescence apices of ga1-3 rgl2-1 rga-t2 35S::RGA-GR for 6 h
caused very little change in AP3, PI, and AG RNA levels, but 8 h
of treatment resulted in a 2-fold reduction of transcript levels of
these three genes (Fig. 1B), which was consistent with the
up-regulation of the expression of these floral homeotic genes by
GA treatment. Thus, B and C function genes are transcription-
ally repressed by RGA, which is the major mediator of GA
signaling involved in flower development.
However, our results demonstrated that the expression of AP3,
PI, and AG did not respond to RGA activity within 4 h of
treatment by dexamethasone (Fig. 1B). Furthermore, a com-
bined treatment of dexamethasone and cycloheximide, an in-
hibitor of translation, for 6 h did not reveal any alteration of
expression of these genes (data not shown). These results imply
that RGA may control the expression of these floral homeotic
genes in an indirect way. Also, whereas RGA may specifically
regulate the B and C function genes, it does not seem to regulate
AP1 and LFY because their expression did not respond either to
GA treatment or to RGA activity (Fig. 1 and data not shown).
To further confirm that floral homeotic genes act downstream
of GA signaling in later stages of flower development, we
generated ga1-3 35::AG-GR, where a biologically active AG-GR
fusion protein can be induced by dexamethasone (T.I. and
E.M.M., unpublished results). If down-regulation of AG expres-
sion is partially responsible for ga1-3 f loral phenotypes, provi-
sion of additional AG activity by dexamethasone should at least
restore some phenotypic defects. This suggestion was confirmed
by the following observations. Dexamethasone treatment of
ga1-3 35::AG-GR provided functional AG activity, causing the
phenotypic rescue of ga1-3 f lowers with elongated stamens and
pistils (Fig. 5B). At a later stage, stamen development was at
least partially rescued (Fig. 5D), which eventually resulted in
partial fertility (Fig. 5F). However, mock-treated plants still
Fig. 5. Partial rescue of flower phenotype in ga1-3 by a biologically active
AG-GR fusion. (A, C, and E) Mock-treated ga1-3 35S::AG-GR plants. (B, D, and
F) Dexamethasone-treated ga1-3 35S::AG-GR plants. Plants were treated
twice within a 1-day interval. Seven days after the first treatment, mock-
treated plants had similar inflorescences (A) to ga1-3 whereas the inflores-
cences of dexamethasone-treated plants (B) developed flowers with elon-
gated stamens and pistils. After one month, the most advanced flowers of
mock-treated plants (C) contained withering stamens, and later they were
completely sterile (E). The most advanced flowers of dexamethasone-treated
plants (D) contained developing stamens, and later they were partially fertile
(F). Dexamethasone treatment itself had no effects on the development of
ga1-3 mutants.
Fig. 4. A biologically active RGA-GR fusion. (A and B) Phenotypes of ga1-3
rga-t2 35S::RGA-GR. Mock-treated plants (A) had the same phenotypes as
ga1-3 rga-t2 whereas plants treated with 10 M dexamethasone (B) devel-
oped as ga1-3. (C–F) Phenotypes of ga1-3 rgl2-1 rga-t2 35S::RGA-GR. Inflores-
cences (C) and flowers (D) of mock-treated plants had the same phenotypes as
ga1-3 rgl2-1 rga-t2 whereas inflorescences (E) and flowers (F) of dexametha-
sone-treated plants mimicked the phenotypes of ga1-3 rgl2-1. All plants were
treated continuously once a week.
Yu et al. PNAS  May 18, 2004  vol. 101  no. 20  7831
PL
A
N
T
BI
O
LO
G
Y
developed as ga1-3, with retarded growth of all f loral organs and
infertility (Fig. 5 A, C, and E). These observations suggest that
the promotion of AG is necessary for continued development of
reproductive organs, and that AG is a target of GA signaling in
flower development.
Taken together, the work presented here suggests that GA
promotes normal development of f loral organs partly by
up-regulating the expression of f loral homeotic genes AP3, PI,
and AG. GA achieves this effect by suppressing the function of
two DELLA proteins, RGA and RGL2. It has been shown
recently that GA regulates cell elongation in filament devel-
opment and cellular differentiation in anthers leading from
microspore to mature pollen grains (29). Our results indicate
that GA may perform these functions by regulating the late
functions of f loral homeotic genes. Indeed, continuous AG
activity seems to be necessary for promoting the growth of WT
stamens with sporogenous cells, elongated filaments, and
dehiscent 4-loculed anthers (T.I. and E.M.M., unpublished
results). Thus, GA signaling in f lower development is possibly
coordinated by a regulatory network involving DELLA pro-
teins and f loral homeotic genes.
The absence of typical DNA-binding domains in DELLA
proteins indicates that these transcriptional regulators may form
complexes with other transcription factors to control the expres-
sion of downstream genes (18, 22, 23, 42). Because DELLA
proteins function in a wide range of plant developmental pro-
grams, their involvement in flower development may be medi-
ated by additional f lower-specific regulators. It will be interest-
ing to clarify whether floral homeotic genes are simply the
downstream targets of DELLA proteins, or, alternatively,
whether they may also interact with DELLA proteins as region-
specific cofactors.
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